High-Throughput Sequencing Reveals Immunological Characteristics of the TRB-/IgH-CDR3 Region of Umbilical Cord Blood - 25/08/16
, Ying Yang, MD, PhD 1, Xin Liu, PhD 1, 2, Lisha An, MD 1, Ruikun Cai, PhD 1, Meng Du, MD 1, 3, Guangyu Wang, MD 1, Yue Qiu, MD 1, 3, Zuoqi Peng, MD 1, Jian Han, MD, PhD 4, Shuhua Ni, PhD 5, Xuerui Tan, MD, PhD 5, Li Jin, MD 6, Song Yu, MD 7, Huiying Wang, MD 8, Chunlin Wang, PhD 1, 9, Xingyu Wang, MD, PhD 1, 2, Xu Ma, MD, PhD 1, 3Abstract |
Objective |
To compare the differences of immunological characteristics between newborn and adults, we performed high-throughput sequencing to reveal the diversity of umbilical cord blood and adult peripheral blood at both T-cell receptor beta chain (TRB) and immunoglobulin heavy chain (IGH) levels.
Study design |
High-throughput sequencing was performed to analyze the expression of TRB-CDR3 and IGH-CDR3 in circulating T and B cells isolated from 20 healthy adults, 56 pregnant women, and 40 newborns.
Results |
Our results revealed different immunological characteristics between newborn and adults, such as distinctive complementarity determining region 3 (CDR3) lengths, usage bias of variable and joining segments, random nucleotide addition, a large number of unique CDR3 peptides, and a greater repertoire diversity. Moreover, each newborn had a distinctive TRB-/IGH-CDR3 repertoire that was independent of the maternal immune status.
Conclusions |
This study presents comprehensive, unrestricted profiles of the TRB/IGH-CDR3 repertoire of newborns, pregnant women, and healthy adults at a sequence-level resolution. Our data may contribute to a better understanding of the immune system of newborns and benefit the efficient application of umbilical cord blood transplantation in future.
Le texte complet de cet article est disponible en PDF.Keywords : umbilical cord blood, high-throughput sequencing, TRB-/IgH-CDR3 repertoires
Abbreviations : BM, CDR3, D, D50, HIGH, HSC, HTBI, IGH, IL, J, N addition, NGS, nt, PBMC, PCR, TRB, UCB, V
Plan
| Supported by International Science & Technology Cooperation Program of China (0102012DFB30130). The authors declare no conflicts of interest. |
Vol 176
P. 69 - septembre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
